Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york
3
×
new york blog main
new york top stories
boston blog main
boston top stories
fda
ipo
multiple myeloma
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
acute migrane
agios pharmaceuticals
antibiotics
arvinas
astrazeneca
bain capital
bausch health
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer
cancer drugs
carbapenem-resistant enterobacteriaceae
celgene
david e. shaw
desmoid tumor
detroit
detroit blog main
detroit top stories
dihydroergotamine
dihydroergotamine mesylate
drug discovery
What
ipo
3
×
ipos
activity
biotech
biotechs
chose
close
companies
company
company’s
course
days
development
device
discover
dog
drug
experimental
firm
firms
growing
handiwork
hasn’t
helped
internal
landscape
leading
life
line
make
medical
medicines
migraine
open
pfizer
pipeline
place
prep
q
quarter
Language
unset
Current search:
" new york "
×
ipo
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way